Joy Marion E - Departments of Bioengineering, University of Pittsburgh

基本信息

浏览量：9

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

493 Distinct Correlative Signatures of CD4+helper and Regulatory T Cells Associate with Response to Different Neoadjuvant Immune Checkpoint Inhibitor Combinations in HNSCC

Matthias Brand,Aditi Kulkarni,Housaiyin Li, Pragati Upadhyay,Simon Chiosea,Patricia M Santos,Brian Isett,Joy Marion,Gabriel Sica, Umamaheswar Duvvuri, Seungwon Kim,Mark Kubik, Fei Tu, Tullia C Bruno, Dario AA Vignali,Anthony Cillo, Riyue Bao,Dan P Zandberg,Jing H Wang,Lazar Vujanovic, Robert L Ferris

Regular and Young Investigator Award Abstracts (2024)

引用0浏览0引用

Mdia2 is an Important Mediator of MRTF-A-dependent Regulation of Breast Cancer Cell Migration

Ian Eder, Virginia Yu, Jacob Antonello,Fangyuan Chen,David Gau,Pooja Chawla,Marion Joy,Peter C. Lucas,David Boone,Adrian V. Lee,Partha Roy

MOLECULAR BIOLOGY OF THE CELLno. 10 (2024)

引用0浏览0WOS引用

Randomized Phase II Evaluation of Nivolumab (nivo), or Relatlimab (rela), or Combined Nivo-Rela Lead-in Followed by Nivo-Rela As First Line Therapy for Patients (pts) with Advanced Melanoma (Mel)

Lilit Karapetyan,Arivarasan Karunamurthy,Anthony Cillo, Shuachao Wang,Ryan Campbell Massa,Anjali Rohatgi,Christopher Deitrick,Yana G. Najjar,Diwakar Davar,Jason J. Luke, Cindy Sander,Amy Rose, Elizabeth Rush,Marion Joy,Sheryl Kunning, Riyue Bao,Hong Wang, Tullia C. Bruno,Dario Vignali,John M. Kirkwood

Journal of Clinical Oncologyno. 16_suppl (2024): 9525-9525

引用0浏览0引用

Differences in the Pathological, Transcriptomic, and Prognostic Implications of Lymphoid Structures Between Primary and Metastatic Cutaneous Melanomas

Lilit Karapetyan,Aofei Li,Danielle Vargas De Stefano,Hassan M. Abushukair,Ayah N. Al-Bzour,Andrew Knight, Caroline Layding,Hong Wang,Jin Xu, Jiqiang Yao, Xiaofei Song,Marion Joy,Jonathan Nguyen,Carlos Moran-Segura,Sabrina Bruno,Cindy Sander,Jane Messina,James J. Mule,Walter J. Storkus,John M. Kirkwood

JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 11 (2024)

引用0浏览0WOS引用

Tumor cell p38 inhibition to overcome immunotherapy resistance

Jason Luke,Rebekah Dadey,Ryan Augustin,Sarah Newman, Krishna Singh, Rose Doerfler,Sarah Behr,Patrice Lee,Brian Isett,Christopher Deitrick,Aofei Li,Marion Joy,Carly Reeder,Katelyn Smith,Julie Urban, Lorenzo Sellitto, Mark Jelinek,Susan Christner,Jan Beumer,Liza Villaruz,Aditi Kulkarni,Diwakar Davar,Andrew Poklepovic,Yana Najjar,Dan Zandberg,Adam Soloff,Tullia Bruno,Lazar Vujanović,Heath Skinner,Robert Ferris,Riyue Bao

Research square (2023)

引用0浏览0WOS引用

Vascular Endothelial Profilin-1 Drives a Protumorigenic Tumor Microenvironment and Tumor Progression in Renal Cancer

David Gau,Andrew Daoud,Abigail Allen,Marion Joy,April Sagan,Sanghoon Lee,Peter C. Lucas,Stefan Duensing,David Boone,Hatice U. Osmanbeyoglu,Partha Roy

JOURNAL OF BIOLOGICAL CHEMISTRYno. 8 (2023)

引用2浏览0WOS引用

MRTF Promotes Breast Cancer Cell Motility Through SRF-dependent Upregulation of DIAPH3 Expression

Ian Eder, Virginia Yu,Fangyuan Chen,David Gau,Marion Joy,Peter Lucas,David Boone,Adrian V. Lee,Partha Roy

biorxiv（2023）

引用0浏览0引用

547 Reprogramming of Type I Interferon-Responding Tumor-Reactive T Lymphocytes Associates with Improved Outcomes to Neoadjuvant Doublet Immunotherapy in HNSCC

Lazar Vujanovic,Riyue Bao,Uma Duvvuri,Seungwon Kim,Robert Ferris,Aditi Kulkarni,Patricia Santos,Dan P Zandberg,Simon Chiosea,Housaiyin Li,Brian Isett,Joy Marion,Mark Kubik

Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)

引用0浏览0引用

Identification of Tumor-Intrinsic Drivers of Immune Exclusion in Acral Melanoma

Ryan C. Augustin,Sarah Newman,Aofei Li,Marion Joy,Maureen Lyons,Mary P. Pham,Peter Lucas,Katelyn Smith,Cindy Sander,Brian Isett,Diwakar Davar,Yana G. Najjar,Hassane M. Zarour,John M. Kirkwood,Jason John Luke,Riyue Bao

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn